BACKGROUND: Outcome of surgical correction of atrioventricular septal defects (AVSD) still varies despite enhanced results. We reviewed our 30-year experience with AVSD repair and identified risk factors for mortality and reoperation. METHODS: Between 1975 and 2006, 312 patients underwent surgery for complete AVSD (n = 209; 67.0%), partial AVSD (n = 76; 24.4%), or intermediate AVSD (n = 27; 8.6%). Mean age was 2.4 ± 3.9 years; 142 patients (45.5%) were younger than 6 months. Follow-up was 99.0% complete. RESULTS: There were 26 in-hospital deaths (8.3%) and 6 late deaths (2.1% of 283). Estimated overall survival for the total study population was 91.3%, 90.6%, and 88.6% at 1, 5, and 15 years, respectively. In the multivariable logistic regression analysis, surgical era 1975 to 1995 (p < 0.001) and younger age (p = 0.004) were found to be independent risk factors for early mortality, whereas preoperative AV valve insufficiency showed a tendency toward statistical significance (p = 0.052). Of the hospital survivors, 43 patients required a late reoperation. Estimated freedom from late reoperation was 96.4%, 89.3%, and 81.8% at 1, 5, and 15 years, respectively. Multivariable Cox regression analysis showed associated cardiovascular anomalies (p < 0.001), left AV valve dysplasia (p < 0.001), and absence of cleft closure (p = 0.003) to be independent risk factors for late reoperation. CONCLUSIONS: AVSD repair can be accomplished with good long-term results. Early surgical era, associated cardiovascular anomalies, left AV valve dysplasia, and absence of cleft closure negatively influence survival and risk of reoperation.
BACKGROUND: Outcome of surgical correction of atrioventricular septal defects (AVSD) still varies despite enhanced results. We reviewed our 30-year experience with AVSD repair and identified risk factors for mortality and reoperation. METHODS: Between 1975 and 2006, 312 patients underwent surgery for complete AVSD (n = 209; 67.0%), partial AVSD (n = 76; 24.4%), or intermediate AVSD (n = 27; 8.6%). Mean age was 2.4 ± 3.9 years; 142 patients (45.5%) were younger than 6 months. Follow-up was 99.0% complete. RESULTS: There were 26 in-hospital deaths (8.3%) and 6 late deaths (2.1% of 283). Estimated overall survival for the total study population was 91.3%, 90.6%, and 88.6% at 1, 5, and 15 years, respectively. In the multivariable logistic regression analysis, surgical era 1975 to 1995 (p < 0.001) and younger age (p = 0.004) were found to be independent risk factors for early mortality, whereas preoperative AV valve insufficiency showed a tendency toward statistical significance (p = 0.052). Of the hospital survivors, 43 patients required a late reoperation. Estimated freedom from late reoperation was 96.4%, 89.3%, and 81.8% at 1, 5, and 15 years, respectively. Multivariable Cox regression analysis showed associated cardiovascular anomalies (p < 0.001), left AV valve dysplasia (p < 0.001), and absence of cleft closure (p = 0.003) to be independent risk factors for late reoperation. CONCLUSIONS:AVSD repair can be accomplished with good long-term results. Early surgical era, associated cardiovascular anomalies, left AV valve dysplasia, and absence of cleft closure negatively influence survival and risk of reoperation.
Authors: James D St Louis; Upinder Jodhka; Jeffrey P Jacobs; Xia He; Kevin D Hill; Sara K Pasquali; Marshall L Jacobs Journal: J Thorac Cardiovasc Surg Date: 2014-07-21 Impact factor: 5.209
Authors: Aditya K Kaza; Steven D Colan; James Jaggers; Minmin Lu; Andrew M Atz; Lynn A Sleeper; Brian W McCrindle; Linda M Lambert; Renee Margossian; Ronald V Lacro; Marc E Richmond; Shobha Natarajan; L Luann Minich Journal: Ann Thorac Surg Date: 2011-08-26 Impact factor: 4.330
Authors: Heidi K Al-Wassia; Osman O Al-Radi; Khadijah A Maghrabi; Mawadda A Bayazeed; Murooj M Qattan; Doaa T Ebraheem; Sarah U Gadi; Mernan F Kattan; Reema A Alghamdi; Samaher H Alzabidi; Ahmed M Dohain Journal: Egypt Heart J Date: 2022-07-18
Authors: Emmeline E Calkoen; Jos J M Westenberg; Lucia J M Kroft; Nico A Blom; Mark G Hazekamp; Marry E Rijlaarsdam; Monique R M Jongbloed; Albert de Roos; Arno A W Roest Journal: J Cardiovasc Magn Reson Date: 2015-02-19 Impact factor: 5.364
Authors: Mohammed S M Elbaz; Rob J van der Geest; Emmeline E Calkoen; Albert de Roos; Boudewijn P F Lelieveldt; Arno A W Roest; Jos J M Westenberg Journal: Magn Reson Med Date: 2016-02-28 Impact factor: 4.668
Authors: Vivian P Kamphuis; Jos J M Westenberg; Roel L F van der Palen; Nico A Blom; Albert de Roos; Rob van der Geest; Mohammed S M Elbaz; Arno A W Roest Journal: Int J Cardiovasc Imaging Date: 2016-11-25 Impact factor: 2.357